Multidisciplinary team care and outcomes in FNCLCC grade 3 soft tissue sarcoma: a propensity score–matched and weighted cohort study - Top-Institutions - MDSpire

Multidisciplinary team care and outcomes in FNCLCC grade 3 soft tissue sarcoma: a propensity score–matched and weighted cohort study

  • By

  • Zhangfu Li

  • Xinyu Li

  • Baicheng Yang

  • Xiaoyang Li

  • Luqiang Wang

  • Ting Liu

  • Xinxin Zhang

  • Zhenguo Zhao

  • Libin Xu

  • Helin Feng

  • Zhenfeng Li

  • Shengji Yu

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Cancer Hospital, Chinese Academy of Medical Sciences
    Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #2

    our center
    our center

    Iowa City, Iowa

    Key Differentiators

    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #4

    West China Hospital, Sichuan University
    West China Hospital, Sichuan University

    Chengdu, Sichuan

    Key Differentiators

    • Oncology

  • #5

    Technical University of Munich
    Technical University of Munich

    Munich, Bavaria

    Key Differentiators

    • Oncology

Original Source(s)

Multidisciplinary team care and outcomes in FNCLCC grade 3 soft tissue sarcoma: a propensity score–matched and weighted cohort study

  • by Zhangfu Li, Xinyu Li, Baicheng Yang, Xiaoyang Li, Luqiang Wang, Ting Liu, Xinxin Zhang, Zhenguo Zhao, Libin Xu, Helin Feng, Zhenfeng Li, Shengji Yu

  • June 10, 2026

Related Content

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement